Masimo Reports Third Quarter 2009 Financi... (Rainbow SET technology which has ushered...)

Masimo Reports Third Quarter 2009 Financial Results

Date:11/3/2009

Rainbow SET technology, which has ushered in new noninvasive measurements, including hemoglobin and carbon monoxide."

Masimo also reported that as of October 3, 2009, cash and cash equivalents totaled $174.7 million, up from $146.9 million at January 3, 2009.

Conference Call

Masimo will hold a conference call today at 1:30 p.m. PT (4:30 p.m. ET) to discuss the results. The dial-in numbers are (888) 520-7182 for domestic callers and +1 (706) 679-9937 for international callers. The reservation number for both dial-in numbers is 35275093. A live web cast of the conference call will be available online from the "Investor Relations" page of the Company's corporate website at www.masimo.com. After the live web cast, the call will remain available on Masimo's website through December 3, 2009. In addition, a telephonic replay of the call will be available until November 17, 2009. The replay dial-in numbers are (800) 642-1687 for domestic callers and +1 (706) 645-9291 for international callers. Please use reservation code 35275093.

About Masimo

Masimo (NASDAQ: MASI) develops innovative monitoring technologies that significantly improve patient care-helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through Motion and Low-Perfusion pulse oximetry, known as Masimo SET®, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and objective studies demonstrate Masimo SET provides the most reliable SpO2 and pulse rate measurements even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced Masimo Rainbow SET® Pulse CO-Oximetry(TM), a breakthrough noninvasive blood constituent monitoring platform that can me
'/>"/>

SOURCE Masimo Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12
Related medicine news :

1. The MED Group Signs Preferred Supplier Agreement for Masimo SET(R) Pulse Oximetry Solutions
2. University Medical Center Mainz Completes Installation of Masimo Noninvasive and Continuous Hemoglobin Throughout Their Operating Rooms, Intensive Care Units and Emergency Department
3. FDNY Makes Largest First Responder Purchase of Masimo Rad-57 Pulse CO-Oximeters to Improve Survival of Firefighters and Victims of Carbon Monoxide Poisoning
4. Childrens Hospital Los Angeles Completes Conversion to Masimo SET(R) Pulse Oximetry Technology
5. IRadimed Announces 510K Clearance of the New Non-Magnetic MRidium(TM) MRI IV Pump with Integrated Masimo SET(R) SpO2 Monitoring
6. Masimo and the International Association of Fire Chiefs Launch Nationwide Health & Safety Program to Reduce Firefighter Death and Injury
7. Masimo and Oridion Sign Connectivity Agreement to Integrate Capnostream(TM)20 Portable Bedside Monitors into the Masimo Patient SafetyNet(TM) System
8. The International Association of Fire Fighters and Masimo Team Up on a New Global Campaign to Raise Awareness of Carbon Monoxide-Related Death and Injury Risks for Fire Fighters
9. Masimo to Report Second Quarter 2009 Financial Results on August 4, 2009
10. Masimo Receives FDA Clearance for New Rainbow(R) Resposable(TM) Sensor System
11. Masimo Announces Settlement of Lawsuit

Post Your Comments:

(Date:12/17/2009)... Helped, Healed, and Preserved Good Health , ... ... Association (IHRSA) announced today that as part of its Campaign for ... abilities to make 2010 the year we unite in a national ... daily exercise is highly valued and widely practiced. IHRSA is inviting ...

(Date:12/17/2009)... , , THURSDAY, Dec. 17 (HealthDay News) -- Among teenage ... least one of three common sexually transmitted infections -- ... becoming sexually active, a new study has found. , ... also found that it was common for these patients ... within four to six months after treatment of the ...

(Date:12/17/2009)... of Science in Human Resource Development Degree Online , ... ... -- Open enrollment has begun for Villanova’s newly online ... professionals whose busy schedules can’t accommodate a campus-based program. With ... online in March 2010, location is no longer a barrier ...

(Date:12/17/2009)... SAN DIEGO, Dec. 17 Neurocrine Biosciences, Inc. ... entered into a privately negotiated transaction to sell an ... to affiliates of Venrock at a price of $2.09 ... approximately $10 million. Neurocrine expects the financing to close ... closing conditions. ,, A shelf registration statement ...

(Date:12/17/2009)... Procedure Provides Efficient Mechanism to Pursue Approval ... Dec. 17 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: ... it has initiated the regulatory approval process ... under the Decentralized Procedure (DCP). The DCP ... company to simultaneously pursue regulatory approval for ...

Breaking Medicine News(10 mins):Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 2 Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 3 Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 4 Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 5 Health News:STDs Common Among Sexually Active Teen Girls in Cities 2 Health News:A World-Class HR Master's Degree Is Now Within Reach – 100% Online 2 Health News:A World-Class HR Master's Degree Is Now Within Reach – 100% Online 3 Health News:Neurocrine Announces Sale of 4,784,689 Shares of Common Stock, to Raise Proceeds of $10 Million 2 Health News:Neurocrine Announces Sale of 4,784,689 Shares of Common Stock, to Raise Proceeds of $10 Million 3 Health News:Labopharm Initiates Regulatory Approval Process for Twice-Daily Tramadol-Acetaminophen in Europe 2 Health News:Labopharm Initiates Regulatory Approval Process for Twice-Daily Tramadol-Acetaminophen in Europe 3

[0] IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active [0] STDs Common Among Sexually Active Teen Girls in Cities [0] A World-Class HR Master's Degree Is Now Within Reach – 100% Online [0] Neurocrine Announces Sale of 4,784,689 Shares of Common Stock, to Raise Proceeds of $10 Million [0] Labopharm Initiates Regulatory Approval Process for Twice-Daily Tramadol-Acetaminophen in Europe

... AARP asks,Governor Schwarzenegger to fight on behalf ... the State Children,s Health,Insurance Program (SCHIP). The U.S. ... and extend SCHIP, covering millions of low-income,uninsured children ... to veto,any bill that would expand the program ...

... National Board of Medical,Examiners is appealing the decision ... which granted the petition of breastfeeding,mother Sophie Currier ... "Our overriding concerns are fairness to all examinees ... an important gateway to medical,practice," said Joseph F. ...

... exclusive North American rights to bepotastine for nasal ... ... 26 ISTA,Pharmaceuticals, Inc. (Nasdaq: ISTA ), announced today it ... an,investigational product for the treatment of allergy symptoms, from Tanabe,Seiyaku Co., ...

... Offers Families Information, Access to Experts and Advice on how to ... Navigate Health Care System ... Speaker, NEW YORK, Sept. 26 Nearly 10 million women,and one ... yet to be clinically identified and treated. How does,one identify an eating ...

... the fall season has,officially begun, the need to protect four-legged ... original,online home of animal health news, offers pet owners these ... -- Fleas are the most common external parasite in cats ... humid environments and feed on the blood of their ...

... to the National,Breast Cancer Foundation, nearly 200,000 women will ... lives, and while it is,widely known that a mammogram ... of women either can,t afford to receive testing or ... to mammograms for,women in underserved communities, Colgate-Palmolive (NYSE: ...

Other Medicine News:Health News:AARP Calls on Governor Schwarzenegger to Discourage Veto of SCHIP Expansion Bill 2 Health News:ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments 2 Health News:ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments 3 Health News:ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments 4 Health News:ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments 5 Health News:Does your Child or Spouse have an Eating Disorder? If They Did, Would You Know? 2 Health News:Summer Temperatures Linger, Extend Threat of Parasites 2 Health News:Colgate-Palmolive Partners With the National Breast Cancer Foundation to Provide Education and Free Mammograms 2 Health News:Colgate-Palmolive Partners With the National Breast Cancer Foundation to Provide Education and Free Mammograms 3

AARP Calls on Governor Schwarzenegger to Discourage Veto of SCHIP Expansion Bill NBME Appeals Massachusetts Judge's Reversal of Lower Court in Suit for Extra Break Time During Medical Licensing Exam ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments Does your Child or Spouse have an Eating Disorder? If They Did, Would You Know?Summer Temperatures Linger, Extend Threat of Parasites Colgate-Palmolive Partners With the National Breast Cancer Foundation to Provide Education and Free Mammograms

(Date:12/17/2009)... RALEIGH, N.C., Dec. 17 Pharmaceutical Institute ... from GeneEd, Inc., a company specializing in life ... advanced e-courses, help expand Pharmaceutical Institute,s already extensive ... Institute is a leading provider of specialized training ... a subsidiary of Campbell Alliance. Financial terms ...

(Date:12/17/2009)... PHOENIX, Dec. 17 The Make-A-Wish Foundation ... million donation from the LATISSE ® ... sponsored by Allergan, Inc. ,, Based on the ... a wish come true, the campaign launched earlier ... the Make-A-Wish Foundation by leveraging the excitement around ...

(Date:12/16/2009)... Cell Therapeutics, Inc. (CTI) (Nasdaq ... February 10, 2010 the U.S. Food and ... will review the New Drug Application (NDA) ... aggressive non-Hodgkin,s lymphoma (NHL). ODAC is an ... concerning the efficacy and safety of marketed ...

[0] Pharmaceutical Institute Acquires E-Learning Assets from GeneEd, Inc.[0] The Make-A-Wish Foundation(R) Receives $1 Million Donation from LATISSE(R) Wishes Campaign [0] Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010

... at least 45% additional,reduction in patients' LDL-cholesterol ... May 17, 2007 /PRNewswire-FirstCall/ -- Isis,Pharmaceuticals, Inc. ... clinical trial of ISIS 301012 in patients ... which were,presented in March at the of ...

... 17, 2007 - BioLineRx Ltd. (TASE:,BLRX), Israel's ... containing data from its successfully completed,phase I ... GABA-enhanced,antipsychotic for the treatment of schizophrenia, have ... scientific,conferences. The data will be presented at ...

Other Medicine Technology:Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 2 Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 3 Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 4 Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 5 BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences 2 BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences 3

Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences

Modular Specimen Filing System has five cells that can hold either slides or tissue cassettes....

Shandon Microscope Slide Cabinet with Drawers...

... is the first solid-state,photocoagulator to ... wavelengths. This advanced,laser system makes ... a red or green wavelength,during ... and ensures effective,patient results., For ...

... The PSL utilizes a high luminance white LED ... lightweight, compact design, to give you the freedom ... The PSL Slit Lamp weighs only about 1.5 ... easily and comfortably in your hand. Its ...

Medicine Products:

Shandon Modular Filing System Shandon Microscope Slide Cabinet with Drawers Integre Duo Red and Green Solid State Photocoagulator PSL Portable Slit Lamp

Masimo Reports Third Quarter 2009 Financi...(Rainbow SET technology which has ushered...),Health